Interventional Radiology in Pediatric Oncology

  • Derek J. RoebuckEmail author
  • John M. Racadio
Part of the Pediatric Oncology book series (PEDIATRICO)


Interventional oncology is the image-guided treatment of tumors. Procedures applicable in children with cancer include percutaneous ablation and transarterial therapy and are almost always performed under general anesthesia. Patients are typically referred following discussion in a multidisciplinary team meeting or tumor board.

Percutaneous treatment may be performed with curative or palliative intent and without compromising the effectiveness of other modalities such as chemotherapy or radiation therapy. Several different forms of percutaneous treatment are available, including radiofrequency ablation, microwave ablation, and cryoablation, but the evidence base for each is still quite limited.

Intraarterial delivery of anticancer treatment is attractive, in principle, because of the potential to increase local effectiveness with reduced systemic toxicity. Various techniques are used in children, most commonly for the treatment of retinoblastoma and liver tumors.


Radiofrequency ablation Microwave ablation Cryoablation Intraarterial chemotherapy Chemoembolization 


  1. 1.
    Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT Jr, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why? Radiographics. 2014;34(5):1344–62.CrossRefGoogle Scholar
  2. 2.
    Gomez FM, Patel PA, Stuart S, Roebuck DJ. Systematic review of ablation techniques for the treatment of malignant or aggressive benign lesions in children. Pediatr Radiol. 2014;44(10):1281–9.CrossRefGoogle Scholar
  3. 3.
    Hoffer FA, Daw NC, Xiong X, Anghelescu D, Krasin M, Yan X, et al. A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumors. Cancer. 2009;115(6):1328–37.CrossRefGoogle Scholar
  4. 4.
    Liu B, Zhou L, Huang G, Zhong Z, Jiang C, Shan Q, et al. First experience of ultrasound-guided percutaneous ablation for recurrent hepatoblastoma after liver resection in children. Sci Rep. 2015;5:16805.CrossRefGoogle Scholar
  5. 5.
    Cazzato RL, Garnon J, Ramamurthy N, Koch G, Tsoumakidou G, Caudrelier J, et al. Percutaneous image-guided cryoablation: current applications and results in the oncologic field. Med Oncol. 2016;33(12):140.CrossRefGoogle Scholar
  6. 6.
    Schmitz JJ, Schmit GD, Atwell TD, Callstrom MR, Kurup AN, Weisbrod AJ, et al. Percutaneous cryoablation of extraabdominal desmoid tumors: a 10-year experience. AJR Am J Roentgenol. 2016;207(1):190–5.CrossRefGoogle Scholar
  7. 7.
    Cornelis FH, Marin F, Labreze C, Pinsolle V, Le Bras Y, Midy D, et al. Percutaneous cryoablation of symptomatic venous malformations as a second-line therapeutic option: a five-year single institution experience. Eur Radiol. 2017;27(12):5015–23.CrossRefGoogle Scholar
  8. 8.
    Shaikh R, Alomari AI, Kerr CL, Miller P, Spencer SA. Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option. Pediatr Radiol. 2016;46(8):1179–86.CrossRefGoogle Scholar
  9. 9.
    Whitmore MJ, Hawkins CM, Prologo JD, Marshall KW, Fabregas JA, Yim DB, et al. Cryoablation of osteoid osteoma in the pediatric and adolescent population. J Vasc Interv Radiol. 2016;27(2):232–7. quiz 238.CrossRefGoogle Scholar
  10. 10.
    Lessard AM, Gilchrist J, Schaefer L, Dupuy DE. Palliation of recurrent Ewing sarcoma of the pelvis with cryoablation and somatosensory-evoked potentials. J Pediatr Hematol Oncol. 2009;31(1):18–21.CrossRefGoogle Scholar
  11. 11.
    Lyu T, Wang X, Su Z, Shangguan J, Sun C, Figini M, et al. Irreversible electroporation in primary and metastatic hepatic malignancies: a review. Medicine (Baltimore). 2017;96(17):e6386.CrossRefGoogle Scholar
  12. 12.
    Hara F, Kishikawa T, Tomishige H, Nishikawa O, Nishida Y, Kongo M. A child with adrenocortical carcinoma who underwent percutaneous ethanol injection therapy for liver metastasis. J Pediatr Surg. 2003;38(8):1237–40.CrossRefGoogle Scholar
  13. 13.
    Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115(8):1398–404. 1404.e1391.CrossRefGoogle Scholar
  14. 14.
    Bertelli E, Leonini S, Galimberti D, Moretti S, Tinturini R, Hadjistilianou T, et al. Hemodynamic and anatomic variations require an adaptable approach during intra-arterial chemotherapy for intraocular retinoblastoma: alternative routes, strategies, and follow-up. AJNR Am J Neuroradiol. 2016;37(7):1289–95.CrossRefGoogle Scholar
  15. 15.
    Phillips TJ, McGuirk SP, Chahal HK, Kingston J, Robertson F, Brew S, et al. Autonomic cardio-respiratory reflex reactions and superselective ophthalmic arterial chemotherapy for retinoblastoma. Paediatr Anaesth. 2013;23(10):940–5.CrossRefGoogle Scholar
  16. 16.
    Shields CL, Alset AE, Say EA, Caywood E, Jabbour P, Shields JA. Retinoblastoma control with primary intra-arterial chemotherapy: outcomes before and during the intravitreal chemotherapy era. J Pediatr Ophthalmol Strabismus. 2016;53(5):275–84.CrossRefGoogle Scholar
  17. 17.
    Lungren MP, Towbin AJ, Roebuck DJ, Monroe EJ, Gill AE, Thakor A, et al. Role of interventional radiology in managing pediatric liver tumors. Part 1: Endovascular interventions. Pediatr Radiol. 2018;48(4):555–64.CrossRefGoogle Scholar
  18. 18.
    Roebuck DJ. Alternative approaches for treatment. In: Zimmermann A, Perilongo G, Malogolowkin M, von Schweinitz D, editors. Pediatric liver tumors. Berlin: Springer; 2011. p. 177–88.CrossRefGoogle Scholar
  19. 19.
    Gaba RC. Planning arteriography for yttrium-90 microsphere radioembolization. Semin Intervent Radiol. 2015;32(4):428–38.CrossRefGoogle Scholar
  20. 20.
    Hawkins CM, Kukreja K, Geller JI, Schatzman C, Ristagno R. Radioembolisation for treatment of pediatric hepatocellular carcinoma. Pediatr Radiol. 2013;43(7):876–81.CrossRefGoogle Scholar
  21. 21.
    Ghanouni P, Dobrotwir A, Bazzocchi A, Bucknor M, Bitton R, Rosenberg J, et al. Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study. Eur Radiol. 2017;27(2):732–40.CrossRefGoogle Scholar
  22. 22.
    Shim J, Staruch RM, Koral K, Xie XJ, Chopra R, Laetsch TW. Pediatric sarcomas are targetable by MR-guided high intensity focused ultrasound (MR-HIFU): anatomical distribution and radiological characteristics. Pediatr Blood Cancer. 2016;63(10):1753–60.CrossRefGoogle Scholar
  23. 23.
    Wang S, Yang C, Zhang J, Kong XR, Zhu H, Wu F, et al. First experience of high-intensity focused ultrasound combined with transcatheter arterial embolization as local control for hepatoblastoma. Hepatology. 2014;59(1):170–7.CrossRefGoogle Scholar
  24. 24.
    Streby KA, Geller JI, Currier MA, Warren PS, Racadio JM, Towbin AJ, et al. Intratumoral injection of HSV1716, an oncolytic herpes virus, is safe and shows evidence of immune response and viral replication in young cancer patients. Clin Cancer Res. 2017;23(14):3566–74.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Perth Children’s Hospital and University of Western AustraliaPerthAustralia
  2. 2.Cincinnati Children’s Hospital Medical CenterCincinnatiUSA

Personalised recommendations